Minimal Residual Disease Negativity Is a New End Point of...

Minimal Residual Disease Negativity Is a New End Point of Myeloma Therapy

Harousseau, Jean-Luc, Avet-Loiseau, Herve
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
35
Journal:
Journal of Clinical Oncology
DOI:
10.1200/JCO.2017.73.1331
Date:
September, 2017
File:
PDF, 579 KB
2017
Conversion to is in progress
Conversion to is failed